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he impact of neck and VFA,  NFA  and  WC  increased  signiﬁcantly  from  snorers  to
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between  AHI  and  the  anthropometric  measures  WC  and  BMI,
but  not  NC.  The  reason  why  NC  did  not  show  differences
between  groups  and  was  not  correlated  with  AHI  while  NFA
did,  could  probably  be  due  to  the  greater  impact  of  cervi-
cal  fat  depot  compared  to  NC  on  the  presence  and  severity
of  OSA  in  our  sample.  Thus,  a  greater  amount  of  NFA  to
the  same  perimeter  could  lead  to  a  reduction  of  the  size  of
the  cervical  airway  structures  and  facilitate  upper  airway
collapse.
The  main  limitation  of  our  study  was  the  small  cohort
size;  however,  this  could  be  offset  by  the  prospective
nature  of  the  study  which  allowed  the  measurement  of
anthropometric  values  by  the  same  professional  and  con-
trol  of  the  timing  of  when  sleep  and  imaging  studies  took
place.
This  study  characterizes  the  distribution  of  body  fatbdominal fat accumulation on
he  pathogenesis of obstructive
leep apnea
ear  Editor,
besity  seems  to  play  an  important  role  in  the  pathogenesis
f  obstructive  sleep  apnea  (OSA).1,2 The  prevalence  of  OSA
s  estimated  to  be  around  5--25%  in  the  adult  population,2--4
eaching  up  to  45%  in  obese  subjects.2 However,  it  is  the
ocation  of  body  fat  accumulation  rather  than  the  total
mount  which  seems  to  be  most  relevant  in  assessing  the
isk  of  OSA.3,5 Neck  and  visceral  fat  accumulation  has  been
escribed  as  risk  factors  for  OSA  in  obese  patients.3 Sev-
ral  mechanisms  have  been  proposed  for  the  greater  impact
f  fat  accumulated  in  the  abdomen  and  neck  regions  in
SA  compared  with  the  peripheral  ones:  reduced  pharyn-
eal  lumen  size  due  to  fat  deposition  in  the  airway  walls  and
ncreased  abdominal  pressure  in  the  thorax  reducing  end-
xpiratory  lung  volumes,  consequently  reducing  tracheal
raction  and  increasing  collapsibility  of  the  upper  airway.1
evertheless  the  impact  of  regional  fat  accumulation  on  the
nset  and  progression  of  the  disease  is  unclear  and  studies
nvestigating  this  complex  association  would  be  helpful  for
 better  management  of  these  patients.
The  authors,  therefore,  designed  a  prospective  cross-
ectional  study  which  aimed  to  analyze  and  compare  the
mpact  of  cervical  and  abdominal  fat  accumulation  on  the
resence  and  severity  of  OSA,  in  a  Portuguese  group  of  indi-
iduals  with  suspected  diagnosis.
Overnight  polygraphy  and  CT  scan  of  the  neck  and
bdomen,  for  the  measurement  of  neck  fat  area  (NFA),  sub-
utaneous  abdominal  fat  area  (SFA)  and  visceral  fat  area
VFA),  were  performed  on  a  cohort  of  subjects  attending  our
leep  laboratory  with  symptoms  of  sleep  disordered  breath-
ng,  between  October  2013  and  May  2014.  Body  mass  index
BMI),  neck  circumference  (NC)  and  waist  circumference
WC)  were  recorded.
Fifty-two  patients  were  enrolled  in  the  study:  the
2ean  ±  SD  BMI  was  32.4  ±  4.3  kg/m ,  69.2%  of  the  sub-
ects  were  obese  (BMI  ≥30  kg/m2).  The  subjects  with  OSA
n  =  38,  apnea/hypopnea  index  (AHI)  ≥5  h--1)  had  a  greater
MI,  WC,  NFA  and  VFA  than  those  without  OSA  (n  =  14,  AHI
5  h--1)  (Table  1).  There  was  a  positive  correlation  of  AHI
ith  BMI  (r  =  0.490,  P  <  0.001),  VFA  (r  =  0.417,  P  =  0.002),
C  (r  =  0.417,  P  =  0.002),  NFA  (r  =  0.377,  P  =  0.007),  SFA
r  =  0.308,  P  =  0.026)  and  NC  (r  =  0.282,  P  =  0.04).  The  BMI,
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aevere  OSA  (Table  2).  The  multivariate  stepwise  linear
egression  analysis  was  used  to  analyze  the  independent  fac-
ors  contributing  to  AHI:  only  BMI  and  VFA  were  independent
isk  factors  for  AHI  (model  R2 =  0.303).
Although  more  marked  in  OSA  group  (81.6%),  35,7%  of  iso-
ated  snorers  were  obese,  probably  due  to  the  association  of
besity  with  snoring  and  daytime  sleepiness6 leading  to  the
uspicion  of  OSA.  Among  fat  measures,  VFA  and  NFA  were  sig-
iﬁcantly  higher  in  OSA  subjects.  Both  increased  signiﬁcantly
rom  snorers  to  severe  OSA  and  were  positively  correlated
ith  the  AHI,  although  correlation  between  AHI  and  NFA  was
omewhat  less  strong  than  with  VFA.  In  multivariate  analy-
is,  only  BMI  and  VFA  were  signiﬁcantly  associated  with  AHI,
uggesting  that  VFA  had  a  greater  impact  on  the  increasing
everity  of  OSA  in  our  sample.  The  association  of  OSA  with
everal  body  habitus  measures  has  been  studied  and  results
ary  widely  among  trials.  At  present,  there  is  no  consensus
hat  any  one  particular  habitus  phenotype  is  more  important
n  the  pathophysiology  of  OSA.  It  is  possible  that  differ-
nt  types  of  fat  distribution  are  more  important  in  speciﬁc
ubgroups  deﬁned  by  factors  such  as  sex4,7 or  ethnicity.7,8
urthermore  the  impact  of  body  habitus  as  a  predictor  of
SA  may  vary  with  age.9
In  this  study,  we  found  a  signiﬁcant  positive  correlationccumulation  in  our  OSA  patients,  analyzes  its  association
ith  disease  severity,  and  assesses  the  location  of  fat
istribution  with  the  greatest  impact  on  the  disease.  These
ndings  suggest  a  complex  association  of  interactive  effects
etween  visceral  fat  and  OSA,  with  pathophysiologic  and
herapeutic  implications.  Continuous  positive  airway  pres-
ure  has  proven  beneﬁcial  in  these  patients3 and  they  could
lso  beneﬁt  from  personalized  nutrition  interventions,
RESEARCH  LETTERS  241
Table  1  Patient  characteristics  and  comparisons  of  the  demographics,  clinical  parameters  and  the  CT  scan  measurements
between the  subjects  with  and  without  OSA.
Overall  Snorers  (IAH  <5)  OSA  (IAH  ≥5)  P-value
Number  of  subjects  52  14  (26.9%)  38  (73.1%)
Men:women  36:16  10:4  26:12  N.S.**
Age  (years)  54.0  ±  11.0  49.8  ±  10.2  55.5  ±  11.1  N.S.*
BMI  (kg/m2)  32.4  ±  4.3  30.0  ±  1.8  33.3  ±  4.7  P  =  0.001*
Obese  36  (69.2%)  5  (35.7%)  31  (81.6%)  P  =  0.003**
NC  (cm)  41.4  ±  4.0  40.0  ±  4.3  42.0  ±  3.8  N.S.*
WC  (cm)  106  ±  9.6  100.3  ±  7.0  108.9  ±  9.5  P  =  0.001*
NFA  (cm2) 38.4  ±  21.4 26.8  ±  11.1 42.9  ±  22.9  P  =  0.016*
VFA  (cm2) 166.7  ±  75.4 115.8  ±  39.7 185.5  ±  77.1 P  <  0.001*
SFA  (cm2) 276  ±  95.5 245.1  ±  69.6 287.4  ±  101.8 N.S.*
AHI: apnea/hypopnea index; BMI: body mass index; NC: neck circumference; NFA: neck fat area; SFA: subcutaneous fast area; TFA: total
fat area; VFA: visceral fat area; WC: waist circumference; OSA: obstructive sleep apnea.
* Student’s t-test.
** Chi-square.
Table  2  Comparison  of  BMI,  neck  and  waist  circumferences  and  cervical  and  abdominal  fat  areas  among  snorers  and  OSA
subjects of  different  severity.
Snorers  Mild  OSA  Moderate  OSA  Severe  OSA  P-value
Number  of  subjects  14  (26.9%)  12  (23.1%)  14  (26.9%)  12  (23.1%)  --
BMI (kg/m2)  30.0  ±  1.8  32.9  ±  5.4  31.8  ±  2.4  35.3  ±  5.4  P  =  0.014
NC (cm)  40.0  ±  4.2  41.1  ±  5.3  42.1  ±  2.1  42.6  ±  3.7  N.S.
WC (cm)  100.3  ±  7.0  107.2  ±  14.7  108.3  ±  6.3  111.3  ±  5.7  P  =  0.022
NFA (cm2)  26.8  ±  11.1  36.2  ±  17.6  42.6  ±  25.5  49.9  ±  23.9  P  =  0.042
VFA (cm2)  115.8  ±  39.7  170.3  ±  65.6  189.6  ±  95.4  195.9  ±  67.4  P  =  0.019
SFA (cm2)  245.1  ±  69.6  264.7  ±  107.0  269.7  ±  93.4  330.6  ±  100.6  N.S.
AHI: apnea/hypopnea index; BMI: body mass index; NC: neck circumference; NFA: neck fat area; SFA: subcutaneous fast area; VFA:
visceral fat area; WC: waist circumference; OSA: obstructive sleep apnea.
exercise  programs,  or  even  surgical  interventions,  with  the
aim  of  reducing  intra-abdominal  visceral  fat.
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Clinical and functional impact
of inhaled antibiotics in a
Portuguese Pulmonology
Department
To  the  Editor,
Chronic  infection  by  gram-negative  agents  is  associated  with
progressive  deterioration  of  lung  function  and  clinical  wors-
ening  of  patients  with  respiratory  disease.1
Inhaled  antibiotics  have  been  effectively  administered
with  safety  and  efﬁcacy  in  these  patients,  particular  in  cystic
ﬁbrosis,  bronchiectasis  and  in  the  prevention  and  treatment
of  patients  with  pneumonia,  with  promising  results.2--4
Chronic  suppressive  therapy,  the  proactive  use  of  an
antibiotic  regimen  rather  than  the  reactive  use  of  antibiotics
following  patient  deterioration,  has  become  the  standard  of
care  over  the  last  decade.5
c
g
s
i
o
f
w
i
a
t
i
p
c
2
S
w
t
i
d
(
y
2
p
(
was  prescribed  in  54.5%  (n  =  18)  of  patients,  tobramycin
in  42.4%  (n  =  14)  and  aztreonam  in  one  patient.  We
found  overlapping  in  the  pre-and  post-treatment  func-
tional  assessment  (FEV1: 45.9  ±  19.6%  vs.  47.2  ±  20.7%,
p  = 0.43;  FVC:  68.8  ±  20.4%  vs.  69.4  ±  21.5%,  p  =  0.75,  IT:
56.1  ±  15.3%  vs.  55.7  ±  14.9%,  p  =  0.71).  Nevertheless,
considering  the  different  pathologies  as  cystic  ﬁbrosis  or
non-cystic  ﬁbrosis,  statistically  signiﬁcant  post  treatment
functional  differences  were  observed  (FEV1:  54.77  ±  20.61%
vs.  39.08  ±  18.16%,  p  =  0.038;  FVC:  76.97  ±  24.25%  vs.
61.29  ±  14.99%,  p  =  0.046).  Comparing  the  groups  of  the
two  most  prescribed  antibiotics,  there  were  no  clinical  and
functional  signiﬁcant  differences.
Signiﬁcant  clinical  improvement  was  observed,  with  a
reduction  in  the  number  of  exacerbations  and  hospital-
izations,  6 months  after  the  start  of  inhaled  antibiotic
therapy  (number  of  exacerbations:  1.94  ±  0.9  vs.  0.82  ±  0.6,
p  < 0.001,  number  of  hospital  admissions:  1.03  ±  1.5  vs.
0.45  ±  0.8,  p =  0.002).  The  reduction  in  the  number  of  exa-
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patients  with  colonization  by  P.  aeruginosa, without  devel-Inhaled  antimicrobial  therapy  is  frequently  used  in
hronic  suppressive  regimens,  and  has  the  advantage  of  tar-
eting  the  site  of  infection  and  achieving  higher  antibiotic
putum  concentrations  within  the  airway  surface  liquid  than
ntravenous  antibiotics.6,7
Here,  the  authors  evaluate  the  efﬁcacy  and  safety
f  inhaled  antibiotics,  as  continued  and  support  therapy,
or  patients  with  respiratory  disease  chronically  colonized
ith  Pseudomonas  aeruginosa, determine  if  the  admin-
stration  of  antimicrobials  in  the  respiratory  tract  was
ssociated  with  clinical  and  functional  improvement  in
hese  patients  and  also  veriﬁed  if  the  administration  of
nhaled  antibiotics  changes  the  microorganisms’  sensitivity
roﬁle.
We  retrospectively  analyzed  the  demographic  and  clini-
al  characteristics  of  patients  who  inhaled  antibiotics  during
013  in  the  Pulmonology  Department  of  Centro  Hospitalar  de
ão  João,  a  hospital  in  the  northern  region  of  Portugal,  as
ell  as  evaluated  the  functional  differences  and  the  sensi-
ivity  proﬁle  in  the  6  months  before  and  after  initiation  of
nhaled  therapy.
A total  of  33  patients  were  on  inhaled  antibiotics
uring  this  period,  54.5%  (n  =  18)  were  male  and  45.5%
n  =  15)  female,  with  an  average  age  of  35  years  (25--54
ears).  Of  these  patients,  54.5%  (n  =  18)  had  cystic  ﬁbrosis,
4.2%  (n  =  8)  bronchiectasis,  12.1%  (n  =  4)  were  trans-
lanted  lung,  6.1%  (n  =  2)  diffuse  pulmonary  disease  and  3%
n  =  1)  had  amyotrophic  lateral  sclerosis.  Inhaled  colistin
o
serbations  was  more  evident  in  the  group  non-cystic  ﬁbrosis
han  in  the  cystic  ﬁbrosis  patients,  and  this  difference
as  statistically  signiﬁcant  (0.6  ±  0.632  vs.  1.0  ±  0.485,
 = 0.048,  respectively).
About  tolerance  to  the  antibiotic  prescribed,  84.8%
n  = 28)  of  patients  did  not  experience  any  side  effects  asso-
iated  with  the  drug;  however,  5  patients  (15.2%)  required
ts  suspension  due  to  headache,  upper  abdominal  pain  and
ral  clefts.
All  antibiotics  prescribed  regimens  produced  a  reduc-
ion  in  sputum  volume  and  there  was  no  development  of
ighly  resistant  strains  throughout  the  study,  the  inhaled
ntimicrobial  therapy  did  not  change  the  microorganisms’
ensitivity  proﬁle.
In  the  literature  several  studies  showed  similar  results,
linical  improvement,  lower  risk  of  acute  exacerbations
nd  risk  reduction  of  unscheduled  admissions  in  patients
n  inhaled  antibiotic  therapy.  In  Portugal,  epidemiological
tudies  are  scarce,  with  results  mainly  in  ventilator-
ssociated  pneumonia.
Although  the  data  collected  was  only  from  patients  fol-
owed  in  the  Pulmonology  outpatient  clinic,  therefore  it  is
ot  representative  of  the  all  population,  the  results  support
he  beneﬁt  of  inhaled  antibiotics,  in  maintenance  regime,
o  reduce  the  number  of  admissions  and  exacerbations  inpment  of  resistant  strains  and,  in  most  patients,  without
ide  effects.
